Company Filing History:
Years Active: 2001-2003
Title: Gertraud Ehrlich-Weinreich: Innovator in HCV Peptide Antigens
Introduction
Gertraud Ehrlich-Weinreich is a prominent inventor based in Gräfeling, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the development of peptide antigens for the determination of Hepatitis C Virus (HCV) antibodies. With a total of 2 patents, her work has the potential to impact vaccine development and antibody production.
Latest Patents
Her latest patents focus on novel HCV peptide antigens that represent partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are designed to be suitable for the determination of HCV antibodies. They serve as immunogens for the production of antibodies against HCV and as vaccines for the development of effective treatments against the virus.
Career Highlights
Gertraud currently works at Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. Her role involves research and development aimed at improving diagnostic methods for HCV. Her innovative approach has garnered attention in the scientific community.
Collaborations
Throughout her career, Gertraud has collaborated with notable colleagues, including Christoph Seidel and Hubert Bayer. These partnerships have enhanced her research efforts and contributed to the advancement of HCV diagnostics.
Conclusion
Gertraud Ehrlich-Weinreich is a key figure in the development of HCV peptide antigens, with her work paving the way for improved diagnostic and therapeutic options. Her contributions to the field are invaluable and continue to influence medical research.